Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

LAUREL HEALTH ADVISORS LLC

UEI: R9QLUC8QLXD8CAGE: 91BU2

LAUREL HEALTH ADVISORS LLC is a federal contractor, registered under UEI R9QLUC8QLXD8 and CAGE code 91BU2. It has been awarded $344,200 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Registration

UEI Code

R9QLUC8QLXD8

CAGE Code

91BU2

Entity Structure

Partnership or Limited Liability Partnership

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability CompanyWoman-Owned BusinessWomen-Owned Small Business

NAICS Codes

541219Other Accounting Services
541611Administrative Management and General Management Consulting Services(Primary)
541613Marketing Consulting Services
541618Other Management Consulting Services
541690Other Scientific and Technical Consulting Services
+2 more

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Laurel Health Advisors LLC specializes in research and development within the social sciences and humanities, delivering evidence-based policy analysis and behavioral insights to inform federal decision-making. Their core capabilities include qualitative and quantitative research design, stakeholder...

Laurel Health Advisors LLC specializes in research and development within the social sciences and humanities, delivering evidence-based policy analysis and behavioral insights to inform federal decision-making. Their core capabilities include qualitative and quantitative research design, stakeholder engagement methodologies, program evaluation frameworks, and data-driven policy recommendations tailored to public sector needs. The firm leverages rigorous social science methodologies to assess program effectiveness, identify systemic barriers, and support the development of equitable, human-centered interventions. Their technical expertise spans survey instrument development, ethnographic analysis, policy modeling, and stakeholder mapping—particularly in contexts requiring nuanced understanding of institutional behavior and community dynamics. A key differentiator is their focus on translating complex social data into actionable policy pathways, ensuring research outcomes are both academically robust and operationally viable for federal implementation. The company has established a direct working relationship with the General Services Administration, providing research services under Federal Supply Schedule contracts to support administrative efficiency, procurement policy analysis, and organizational behavior studies. This engagement reflects a pattern of delivering non-technical, human-focused research that complements GSA’s mission to optimize government operations through informed policy design. Laurel Health Advisors operates primarily within NAICS 541720, focusing on applied social science research that informs federal governance, program integrity, and public service delivery. Their market positioning centers on bridging academic rigor with practical policy needs, serving as a trusted advisor for agencies seeking to embed behavioral science and social context into operational planning. As a Women-Owned Small Business and Woman-Owned Business certified firm based in Laurel, Maryland, Laurel Health Advisors brings a distinctive perspective to federal contracting, emphasizing inclusive research practices and diverse analytical approaches. Their small-business structure enables agile, client-responsive engagement, while their certifications affirm their commitment to diversity in federal contracting ecosystems.

Key Performance Metrics

Awards Count

6

All time

Active

0

Currently performing

Completed

6

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
- Unknown NAICS$344.2K100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with LAUREL HEALTH ADVISORS LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for LAUREL HEALTH ADVISORS LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in LAUREL HEALTH ADVISORS LLC's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding for U.S. small business concerns (SBCs) to conduct research and development of commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants must be for-profit entities located in the U.S., owned more than 50 percent by U.S. citizens or permanent residents, and employ no more than 500 people. The program accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being NIH-specific options to accelerate development. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on an overall impact score, considering commercial potential, technical feasibility, and the quality of the commercialization plan. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines; notably, several institutes, including NIAID and NIAMS, do not accept clinical trials under this NOFO. Applicants must maintain active registrations in SAM, possess a Unique Entity Identifier, and comply with cybersecurity incident reporting requirements, including notifying HHS within 48 hours of a discovery.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the project toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being specific to the NIH. Budget limits vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the environment for success. While clinical trials are generally optional, they are prohibited for specific components, including all FDA centers and several NIH institutes such as NIAMS and NIDCR. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. All applications must be submitted electronically, with a final expiration date of April 06, 2027.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage research and development to full commercialization. This program is specifically available to recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including technical assistance for regulatory and intellectual property strategies, manufacturing scale-up, independent replication of key studies, and clinical trials. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible applicants must be for-profit organizations with no more than 500 employees and maintain active registrations in the System for Award Management and the SBA Company Registry. Project periods are limited to a maximum of three years, with budget ceilings varying by participating Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via NIH peer review based on scientific and technical merit, commercial potential, and relevance to program priorities. Key submission requirements include a detailed regulatory plan and a CRP progress report, while costs for patent or FDA filing fees and separate Technical and Business Assistance funding are strictly prohibited.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details